You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage I adult lymphoblastic lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

Completed
Has Results
  • B-cell Lymphoma
  • +2 more
  • BI-1206 single agent dose escalation phase
  • +3 more
  • Leicester, England, United Kingdom
  • +4 more
Jun 17, 2021

Aging Disorder Trial in Vandoeuvre les Nancy (PET with a cerebral step, Central blood pressure measurement, Neurocognitive

Active, not recruiting
  • Aging Disorder
  • PET with a cerebral step
  • +2 more
  • Vandoeuvre les Nancy, France
    CHRU Nancy
Sep 30, 2021

Childhood Asthma Trial in Mansoura (Buteyko Breathing Technique)

Completed
  • Childhood Asthma
  • Buteyko Breathing Technique
  • Mansoura, Egypt
    Mansoura University
May 21, 2022

Clear Aligners and Metal Brackets on Nutritional Status

Recruiting
  • Malocclusion
    • Istanbul, Turkey
      Marmara University School of Dentistry
    Jul 7, 2023

    Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

    Terminated
    • Neuroblastoma
    • Cancer
    • Biopsy
    • +12 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jan 31, 2023

    Obstructive Sleep Apnea Trial in Namur (Sulthiame)

    Recruiting
    • Obstructive Sleep Apnea
    • Namur, Belgium
      Pneumocare SRL
    Feb 2, 2022

    Pediatric All, Trauma Trial in Winston-Salem

    Completed
    • Pediatric All
    • Trauma
      • Winston-Salem, North Carolina
        Wake Forest University School of Medicine
      Dec 8, 2021

      SNAPS Breast Cancer Patient Study Breast Cancer Patients

      Not yet recruiting
      • Breast Cancer
      • Breast Cancer Female
      • Blood test
      • Durham, North Carolina
        Duke University
      May 12, 2022

      Prophylactic PRP in Moderate NPDR

      Completed
      • Eye Diseases
      • +2 more
      • PRP
      • Assiut, Egypt
        Assiut University
      Sep 14, 2022

      Covid19, Severe Acute Respiratory Syndrome, SARS-CoV-2 Infection Trial in Nijmegen (ABNCoV2 Vaccine)

      Completed
      • Covid19
      • +2 more
      • ABNCoV2 Vaccine
      • Nijmegen, Gelderland, Netherlands
        Radboud univserity medical center
      Mar 16, 2022

      Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

      Active, not recruiting
      • Head and Neck Cancer
      • recombinant thyroid-stimulating hormone
      • Radiodine ablation without rhTSH
      • Brighton, England, United Kingdom
      • +24 more
      Oct 13, 2021

      Carcinoma, Hepatocellular Trial (Regorafenib in combination with nivolumab, Transarterial Chemoembolization (TACE))

      Not yet recruiting
      • Carcinoma, Hepatocellular
      • Regorafenib in combination with nivolumab
      • Transarterial Chemoembolization (TACE)
      • (no location specified)
      Dec 8, 2021

      Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

      Active, not recruiting
      • Stage III Cutaneous Melanoma AJCC v7
      • +4 more
      • Cryosurgery
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 3, 2023

      Healthy Individuals Trial in Sacramento (Monosaccharide Powder, Placebo Comparator)

      Not yet recruiting
      • Healthy Individuals
      • Monosaccharide Powder
      • Placebo Comparator
      • Sacramento, California
        University of California, Davis Medical Center
      Feb 23, 2022

      Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)

      Terminated
      • Advanced Solid Tumors
      • IPH5401 and Durvalumab
      • Louisville, Kentucky
      • +11 more
      Jan 12, 2022

      Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Oct 6, 2022

      Breast Cancer Trial in Toronto (IMRT + CT + MR scan)

      Active, not recruiting
      • Breast Cancer
      • IMRT + CT + MR scan
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Oct 6, 2022

      Patient With Anti-GABAbr Antibodies Associated-encephalitis.

      Completed
      • Autoimmune Encephalitis
      • Long-term outcome
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Feb 14, 2023

      Lung Cancer Trial in Indianapolis (Stereotactic Ablative Radiation Therapy (SABR))

      Withdrawn
      • Lung Cancer
      • Stereotactic Ablative Radiation Therapy (SABR)
      • Indianapolis, Indiana
      • +2 more
      Jan 26, 2022

      Trial (AMG 701)

      Available
        • AMG 701
        • (no location specified)
        Feb 15, 2022

        Identification of New Prognostic Markers for Breast Cancer.

        Recruiting
        • Breast Cancer
        • Conventional treatment protocols of breast cancer
        • Grenoble, France
          UniversityHospitalGrenoble
        Mar 26, 2021

        Patients With Cholangiocarcinoma and Gallbladder Cancer

        Recruiting
        • Biliary Tract Cancer
        • +2 more
          • Herlev, Copenhagen, Denmark
            Herlev & Gentofte Hospital
          Dec 21, 2021

          Pharmacokinetics of Sufentanil After Epidural Administration

          Completed
          • Epidural; Anesthesia
          • +2 more
          • Epidural administration of sufentanil
          • Poznań, Greater Poland, Poland
          • +1 more
          Oct 1, 2023

          Hodgkin Lymphoma Trial (pembrolizumab)

          Active, not recruiting
          • Hodgkin Lymphoma
          • pembrolizumab
          • (no location specified)
          May 30, 2022

          Type1 Diabetes Trial (Oral glucose tolerance test (OGTT), Hyperglycemic clamp test, Continuous glucose monitoring)

          Not yet recruiting
          • Type1 Diabetes Mellitus
          • Oral glucose tolerance test (OGTT)
          • +2 more
          • (no location specified)
          Mar 8, 2023